[go: up one dir, main page]

IT1289608B1 - Composizione per uso terapeutico o diagnostico somministrabile per via intranasale,sublinguale o vaginale - Google Patents

Composizione per uso terapeutico o diagnostico somministrabile per via intranasale,sublinguale o vaginale

Info

Publication number
IT1289608B1
IT1289608B1 IT97MI000217A ITMI970217A IT1289608B1 IT 1289608 B1 IT1289608 B1 IT 1289608B1 IT 97MI000217 A IT97MI000217 A IT 97MI000217A IT MI970217 A ITMI970217 A IT MI970217A IT 1289608 B1 IT1289608 B1 IT 1289608B1
Authority
IT
Italy
Prior art keywords
sublingual
vaginal
therapeutic
composition
diagnostic use
Prior art date
Application number
IT97MI000217A
Other languages
English (en)
Inventor
Vilma Rossi
Mario Pinza
Original Assignee
Angelini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angelini Ricerche Spa filed Critical Angelini Ricerche Spa
Priority to IT97MI000217A priority Critical patent/IT1289608B1/it
Priority to AU63953/98A priority patent/AU6395398A/en
Priority to PCT/EP1998/000650 priority patent/WO1998034645A1/en
Publication of ITMI970217A1 publication Critical patent/ITMI970217A1/it
Application granted granted Critical
Publication of IT1289608B1 publication Critical patent/IT1289608B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT97MI000217A 1997-02-05 1997-02-05 Composizione per uso terapeutico o diagnostico somministrabile per via intranasale,sublinguale o vaginale IT1289608B1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT97MI000217A IT1289608B1 (it) 1997-02-05 1997-02-05 Composizione per uso terapeutico o diagnostico somministrabile per via intranasale,sublinguale o vaginale
AU63953/98A AU6395398A (en) 1997-02-05 1998-02-04 A composition for administration by the intranasal, sublingual or vaginal route
PCT/EP1998/000650 WO1998034645A1 (en) 1997-02-05 1998-02-04 A composition for administration by the intranasal, sublingual or vaginal route

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI000217A IT1289608B1 (it) 1997-02-05 1997-02-05 Composizione per uso terapeutico o diagnostico somministrabile per via intranasale,sublinguale o vaginale

Publications (2)

Publication Number Publication Date
ITMI970217A1 ITMI970217A1 (it) 1998-08-05
IT1289608B1 true IT1289608B1 (it) 1998-10-15

Family

ID=11375858

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97MI000217A IT1289608B1 (it) 1997-02-05 1997-02-05 Composizione per uso terapeutico o diagnostico somministrabile per via intranasale,sublinguale o vaginale

Country Status (3)

Country Link
AU (1) AU6395398A (it)
IT (1) IT1289608B1 (it)
WO (1) WO1998034645A1 (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485726B1 (en) 1995-01-17 2002-11-26 The Brigham And Women's Hospital, Inc. Receptor specific transepithelial transport of therapeutics
US6030613A (en) * 1995-01-17 2000-02-29 The Brigham And Women's Hospital, Inc. Receptor specific transepithelial transport of therapeutics
US6086875A (en) * 1995-01-17 2000-07-11 The Brigham And Women's Hospital, Inc. Receptor specific transepithelial transport of immunogens
US7273618B2 (en) 1998-12-09 2007-09-25 Chiron Corporation Method for administering agents to the central nervous system
ATE289800T1 (de) * 1998-12-09 2005-03-15 Chiron Corp Verwendung eines neurologischen wirkstoffes zur herstellung eines medikamentes zur behandlung von erkrankungen des zentralen nervensystems
CA2479212A1 (en) * 2002-03-15 2003-09-25 Brigham And Women's Hospital, Inc. Central airway administration for systemic delivery of therapeutics
EP2284192A3 (en) 2002-11-08 2011-07-20 Ablynx N.V. Camelidae antibodies for sublingual administration
US9320792B2 (en) 2002-11-08 2016-04-26 Ablynx N.V. Pulmonary administration of immunoglobulin single variable domains and constructs thereof
US20060034845A1 (en) 2002-11-08 2006-02-16 Karen Silence Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
US20090136505A1 (en) 2005-02-23 2009-05-28 Johanna Bentz Intranasal Administration of Active Agents to the Central Nervous System

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE88900T1 (de) * 1987-09-02 1993-05-15 Ciba Geigy Ag Konjugate von interferon alpha mit immunglobulinen.
GB8820377D0 (en) * 1988-08-26 1988-09-28 Offord R E Chemical compounds
KR910009284A (ko) * 1989-11-13 1991-06-28 원본미기재 인체 종양 세포 항원에 특이적인 키메라형 생쥐-인체 a10 항체
AU5958494A (en) * 1992-12-21 1994-07-19 Tanox Biosystems, Inc. Allergen-specific iga monoclonal antibodies and related products for allergy treatment
WO1995013831A1 (en) * 1993-11-17 1995-05-26 The Schepens Eye Research Institute, Inc. Antibody to ocular and vaginal surface epithelium
PT1323346E (pt) * 1995-01-17 2006-10-31 Brigham & Womens Hospital Administracao transepitelial de antigenicos com a finalidade de provocar tolerancia e imunidade
US5766620A (en) * 1995-10-23 1998-06-16 Theratech, Inc. Buccal delivery of glucagon-like insulinotropic peptides
PT885002E (pt) * 1996-03-04 2011-07-14 Massachusetts Inst Technology Materiais e métodos para aumento da internalização celular

Also Published As

Publication number Publication date
AU6395398A (en) 1998-08-26
ITMI970217A1 (it) 1998-08-05
WO1998034645A1 (en) 1998-08-13

Similar Documents

Publication Publication Date Title
EP0983289A4 (en) OLIGONUCLEOTIDE AIDS
DE69702617D1 (de) Wässrige tintenzusammensetzungen
DE69803968D1 (de) Kautschukzusammensetzung
IT238006Y1 (it) Dispositivo massaggiatore,ad elevata semplicita' strutturale,utilizzabile direttamente o inseribile all'interno dello schienale
DE69836722D1 (de) Kautschukzusammensetzung
ID17561A (id) Komposisi untuk pemakaian luar
IT1289608B1 (it) Composizione per uso terapeutico o diagnostico somministrabile per via intranasale,sublinguale o vaginale
IT1297886B1 (it) Nifedipina per uso topico
BR9707078A (pt) Composição de sabão para o corpo
NO994013D0 (no) Spirometer-pusterör
DE69709769D1 (de) Wässrige tintenzusammensetzungen
FR2753622B1 (fr) Speculum, notamment un speculum vaginal a usage unique
DE69823431D1 (de) Kautschukzusammensetzung
DK0973790T3 (da) Estra-5(10),7-diener med østrogen aktivitet
ES1041126Y (es) Escobilla desechable de un solo uso.
BR1101089A (pt) Composição terapêutica de uso nasal
FI974120A0 (fi) Lager med laong livslaengd
IT1294083B1 (it) Attacco per uso odontotecnico.
ES1037797Y (es) Mano de mortero multiusos mejorada.
ES1028612Y (es) Impulsor-aspirador de uso clinico.
DE69812731D1 (de) Kautschukzusammensetzung
IT1293783B1 (it) Composizioni gommose per uso orale
DE69725837D1 (de) Pädiatrieset zum einmaligen Gebrauch
IT1268295B1 (it) Presidio ortopedico ad uso universale.
IT1286981B1 (it) Fibrolisore mio-fasciale ad uso fisioterapeutico

Legal Events

Date Code Title Description
0001 Granted